blockade of the renin–angiotensin system has beneficial effects in patients with diabetic nephropathy; however, this treatment can induce aldosterone breakthrough and thus become ineffective. new data indicate that aldosterone breakthrough develops even when maximal doses of an angiotensin-converting-enzyme inhibitor are administered to patients with diabetic nephropa
作 者
相关链接
DOI URL
浙公网安备 33010202000686号 ( 浙ICP备09035230号-1 )
